Your browser doesn't support javascript.
loading
Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.
Coyle, Patricia K; Khatri, Bhupendra; Edwards, Keith R; Meca-Lallana, José E; Cavalier, Steve; Rufi, Pascal; Benamor, Myriam; Brette, Sandrine; Robinson, Miqun; Gold, Ralf.
Afiliação
  • Coyle PK; Department of Neurology, Stony Brook University, HSC T12-020, Stony Brook, NY 11794-8121, USA. Electronic address: Patricia.Coyle@stonybrookmedicine.edu.
  • Khatri B; The Regional MS Center, Center for Neurological Disorders, Wheaton Franciscan Health Care, 3237 S 16th St, Milwaukee, WI 53215, USA. Electronic address: bokhatri@aol.com.
  • Edwards KR; Multiple Sclerosis Center of Northeastern New York, 1205 Troy-Schenectady Rd, Ste 105, Latham, NY 12110, USA. Electronic address: kedwards@tristateneuro.com.
  • Meca-Lallana JE; Hospital Virgen de la Arrixaca, Ctra., Madrid-Cartagena, s/n, 30120 Murcia, Spain; Cátedra de Neuroinmunología Clínica y Esclerosis Múltiple, UCAM Universidad Católica San Antonio de Murcia, Campus de los Jerónimos, Guadalupe, 30107 Murcia, Spain. Electronic address: pmecal@gmail.com.
  • Cavalier S; Sanofi Genzyme, 500 Kendall Street, 6th Floor, Cambridge, MA 02142, USA. Electronic address: steven.cavalier@sanofi.com.
  • Rufi P; Sanofi Genzyme, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France. Electronic address: pascal.rufi@sanofi.com.
  • Benamor M; Sanofi Genzyme, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France.
  • Brette S; Aixial, 4 Rue Barthelemy Danjou, 92100 Boulogne-Billancourt, France. Electronic address: Sandrine.brette@sanofi.com.
  • Robinson M; Sanofi, 55 Corporate Drive, Bridgewater, NJ 08807, USA. Electronic address: Miqun.Robinson@sanofi.com.
  • Gold R; St Josef Hospital, Ruhr University Bochum, 5092414 Gudrunstrasse 56, D-44791 Bochum, Germany. Electronic address: ralf.gold@ruhr-uni-bochum.de.
Mult Scler Relat Disord ; 17: 107-115, 2017 Oct.
Article em En | MEDLINE | ID: mdl-29055438
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toluidinas / Crotonatos / Esclerose Múltipla Recidivante-Remitente / Medidas de Resultados Relatados pelo Paciente / Fatores Imunológicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toluidinas / Crotonatos / Esclerose Múltipla Recidivante-Remitente / Medidas de Resultados Relatados pelo Paciente / Fatores Imunológicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article